Synergistic effects of HDAC inhibitor tucidinostat and ENT inhibitor dipyridamole in T-cell malignancies

by HTLV | Mar 16, 2026 | Publications

Sci Rep. 2026 Mar 15. doi: 10.1038/s41598-026-43642-1. Online ahead of print.

NO ABSTRACT

PMID:41833979 | DOI:10.1038/s41598-026-43642-1

Decoding pathogenesis factors

Decoding pathogenesis factors involved in the progression of ATLL or HAM/TSP after infection by HTLV-1 through a...

HTLV-1 Disease Abstract The years 2020 and 2021 will remain memorable years for many reasons [...]. Click here to...

HTLV-2 Encoded Antisense Protein APH-2 Suppresses HIV-1 Replication Abstract Antisense protein of Human T-cell...